Quality of life (QOL) measurement in patients receiving neoadjuvant therapy in the I-SPY 2 trial. Background: The majority of women diagnosed with breast cancer are overweight or obese, and gain ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback